Medical Devices Startups

Avant Genomics is developing an automated platform for liquid biopsy sample preparation, using an enclosed fluidic cartridge and benchtop instruments that integrate DNA enrichment and purification for blood-based cancer detection. The system targets research labs, clinical testing environments, and reference laboratories aiming to reduce manual labor and cost in precision oncology workflows.

1 investor

Avant Devices makes a conversion kit that transforms a standard manual wheelchair into an electric-powered wheelchair, letting users keep their existing chair. The product targets wheelchair users seeking added mobility.

1 investor

Avantik provides integrated equipment, consumables, lab design services, and training for Mohs histology labs performing same-day surgical pathology. The company serves dermatologists and surgical pathology labs with cryostats, staining systems, and workflow optimization.

1 investor

AVaTAR MedTech develops medical devices for aortic and pulmonary valve disease treatment, addressing surgical needs in underserved patient populations globally. The company combines advanced medical technology with cost-effective solutions to expand access to cardiac surgery procedures.

1 investor

Avenda Health develops Unfold AI, deep learning software that maps a patient's prostate cancer in 3D to give physicians visualization and information for treatment planning. The company serves urologists and physicians treating prostate cancer patients in the medical device and healthcare space.

1 investor

AVEO, operating as a subsidiary of LG Chem, develops and commercializes oncology medicines aimed at cancer patients seeking effective treatments that maintain quality of life. The company operates a portfolio of on-market and in-development therapeutic products globally.

1 investor

Avia Vascular manufactures medical devices designed to reduce venipuncture procedures for blood sampling in hospital inpatients. The company develops technology to improve patient experience, clinical outcomes, and operational costs for healthcare providers.

1 investor

Avidhrt makes the Avidhrt Sense, a portable device that combines a clinical-quality ECG, pulse oximeter, and infrared temperature sensor for at-home heart and vital-sign monitoring. It targets consumers with or at risk of atrial fibrillation, letting them record and share readings with their physicians via iOS and Android devices.

1 investor

Avidicare develops Opragon, a solution designed to benefit patients and hospital staff in healthcare settings.

1 investor

Avion operates a platform using autonomous drones to deliver medical supplies and clinical samples from urban healthcare centers to remote clinics. The service targets healthcare providers serving isolated populations that lack efficient ground-based logistics infrastructure.

1 investor

Avirmax is a preclinical-stage biopharmaceutical company developing AAV-based genetic medicines to treat chronic and degenerative ocular diseases. Through its Avirmax CMC (ACI) division, it also provides bioprocess development and manufacturing services for AAV-based gene therapies to external customers.

1 investor

Avis Hospitals is India's first dedicated chain specializing in advanced vein and vascular care, using minimally invasive techniques and advanced laser technologies. The hospital network serves patients requiring treatment for varicose veins and related vascular conditions.

1 investor

Zimmer Biomet's Avitus Bone & Marrow Harvester is a minimally invasive suction curettage device designed for orthopedic surgeons to harvest cancellous bone and bone marrow, and to debride infected or diseased bone through small incisions at accessible sites like the tibia and calcaneus. The sterile-packed, disposable system enables percutaneous autologous bone and marrow harvesting for surgical grafting procedures.

1 investor

Aviv Clinics operates physician-led clinics offering a personalized hyperbaric oxygen therapy program (the Aviv Medical Program) aimed at improving cognitive and physical performance for people who are aging or recovering from chronic medical conditions. Its UHMS-accredited clinic is located in central Florida and its protocol is based on peer-reviewed hyperbaric medicine research.

1 investor

Avive Health operates hospitals in Australia and is committed to patient safety, clinical governance, and healthcare quality through adherence to national healthcare rights standards and hospital by-laws.

1 investor

Avivo develops enzyme-based technology to convert blood types and enable organ compatibility, increasing access to transfusions and transplants while reducing waste in healthcare systems. The company serves hospitals, transplant centers, military and emergency care settings with a platform designed to integrate into existing clinical workflows.

1 investor

AVROBIO develops ex vivo lentiviral vector-based hematopoietic stem cell gene therapies to treat lysosomal disorders by permanently integrating therapeutic genes into patient stem cells manufactured outside the body. The modified cells differentiate into multiple cell types capable of crossing the blood-brain barrier to deliver treatment throughout the body and central nervous system.

1 investor

AVS Bio raises Specific Pathogen Free (SPF) chickens in US-based biosecurity facilities for use in vaccine manufacturing, quality control testing, and research applications. The company supplies pathogen-free birds of various ages to pharmaceutical, biotech, and research organizations requiring controlled biological systems for regulatory and scientific work.

1 investor

Avvio AMEA develops kidney stone treatment technology for urological care, targeting patients and healthcare providers across Asia, the Middle East, and Africa. It is the regional arm of Avvio Medical, whose investigational medical device has not yet received regulatory clearance.

1 investor

Awanui Labs operates a national network of medical laboratories and blood test collection centres across New Zealand, providing pathology and diagnostic testing services. It unifies eight regional laboratory brands from Northland to Southland under a single national name.

1 investor

Acoustic Wave Cell Therapy develops an acoustic wave-based investigational medical device, currently limited to investigational use under U.S. federal law. The company operates in the urology and medical device field, with a focus related to treatment of conditions such as erectile dysfunction.

1 investor

A life sciences company offering nanopore sequencing instruments and automated library preparation systems for molecular biology research.

1 investor

Geomatikk combines detection services and software to help asset owners, municipalities, and contractors prevent damage to underground infrastructure during excavation and construction work. The company operates across the Nordic region and selected European markets, serving 13,000 customers annually.

1 investor

Axelia Oncology is a biopharmaceutical company developing AXA-042, a selective immunological agent designed to activate innate immune responses against checkpoint-insensitive solid tumors. The company focuses on oncology therapeutics through activation of TLR2/6 pathways.

1 investor